Corporate

Corporate

Breaking Barriers in Science: The Women of DoubleRainbow Biosciences

11 Feb 2023

Corporate

2022: The year of acceleration

30 Dec 2022

Corporate

Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications

Press Release

28 Nov 2022

Corporate

DoubleRainbow Biosciences Announces Strategic AI Collaboration with Galixir

Press Release

7 Nov 2022

Corporate

Double Rainbow Announces Membership with BioMADE

Press Release

20 Oct 2022

Corporate

DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics

Press Release

22 Aug 2022

Corporate

2021: A year in Review

23 Dec 2021

Corporate

Double Rainbow announces $10 million investment from Betta Pharmaceuticals

Press Release

10 Aug 2021